BioCryst Pharmaceuticals grants 18,300 RSUs to new employee.

BioCryst Pharmaceuticals has granted 18,300 restricted stock units (RSUs) to a newly-hired employee as an inducement to join the company. The RSUs vest in four equal annual installments and are subject to the employee's continued service with BioCryst. The grant was made in accordance with Nasdaq Listing Rule 5635(c)(4) and is governed by BioCryst's Inducement Equity Incentive Plan and a restricted stock unit agreement.